Scarica l'app Stockscreener
77.00
2.79%
-2.21
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$79.21
Aprire:
$78.42
Volume 24 ore:
363.77K
Relative Volume:
0.66
Capitalizzazione di mercato:
$2.94B
Reddito:
-
Utile/perdita netta:
$-241.60M
Rapporto P/E:
-11.64
EPS:
-6.6167
Flusso di cassa netto:
$-201.34M
1 W Prestazione:
+3.89%
1M Prestazione:
+5.28%
6M Prestazione:
-0.41%
1 anno Prestazione:
+28.85%
Intervallo 1D:
$75.01
$79.31
Intervallo di 1 settimana:
$71.62
$79.36
Portata 52W:
$40.00
$99.50
Disc Medicine Inc Stock (IRON) Company Profile
Nome
Disc Medicine Inc
Settore
Industria
Telefono
(617) 674-9274
Indirizzo
321 ARSENAL STREET, SUITE 101, WATERTOWN
Compare IRON vs VRTX, REGN, ARGX, RVMD, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
IRON
Disc Medicine Inc
|
77.00 | 2.85B | 0 | -241.60M | -201.34M | -6.6167 |
VRTX
Vertex Pharmaceuticals Inc
|
477.10 | 121.57B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
762.63 | 69.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
853.82 | 55.61B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
187.53 | 39.98B | 742.00K | -1.37B | -1.07B | -7.0731 |
ONC
Beone Medicines Ltd Adr
|
316.01 | 33.81B | 5.76B | 514.49M | 1.10B | 4.4813 |
Disc Medicine Inc Stock (IRON) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-03 | Ripresa | Stifel | Buy |
| 2025-07-21 | Iniziato | Truist | Buy |
| 2025-07-03 | Ripresa | Morgan Stanley | Overweight |
| 2025-06-11 | Ripresa | Raymond James | Strong Buy |
| 2025-02-27 | Iniziato | TD Cowen | Buy |
| 2024-11-05 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-11-04 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2024-10-23 | Iniziato | Jefferies | Buy |
| 2024-10-16 | Iniziato | Scotiabank | Sector Outperform |
| 2024-08-22 | Iniziato | Wells Fargo | Overweight |
| 2024-04-01 | Downgrade | Raymond James | Strong Buy → Outperform |
| 2023-12-19 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2023-06-09 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2023-06-07 | Iniziato | H.C. Wainwright | Buy |
| 2023-05-17 | Iniziato | Raymond James | Outperform |
| 2023-04-28 | Iniziato | Cantor Fitzgerald | Overweight |
| 2023-04-21 | Iniziato | Stifel | Buy |
| 2023-04-20 | Iniziato | Morgan Stanley | Overweight |
| 2023-03-23 | Iniziato | BMO Capital Markets | Outperform |
| 2023-02-28 | Iniziato | SVB Securities | Outperform |
Mostra tutto
Disc Medicine Inc Borsa (IRON) Ultime notizie
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - Morningstar
Disc Medicine Stock Slumps After FDA Declines Approval For Inherited Disorder Drug Over Efficacy Concerns - Stocktwits
TradingKey - TradingKey
Disc Medicine Inc (IRON) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Disc Medicine Inc (IRON) Institutional Confidence - TradingKey
Disc Medicine Inc (IRON) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IRON|Disc Medicine Inc|Price:74.120|Chg%:-1.740 - TradingKey
Disc Medicine Inc (IRON) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
IRON|Disc Medicine Inc|Price:74.640|Chg%:+0.520 - TradingKey
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Verra Mobility Corporation Investors with Losses to Secure Counsel Before Important August 4 Deadline in Securities Class Action - GlobeNewswire Inc.
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights - GlobeNewswire Inc.
Price to earnings forward of Disc Medicine, Inc. – NASDAQ:IRON - TradingView
Going Deeper On Disc Medicine (NASDAQ:IRON) - Seeking Alpha
Disc Medicine, Inc. (IRON) Stock Analysis: Biotech Innovator With 36.52% Upside Potential - DirectorsTalk Interviews
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - ACCESS Newswire
(IRON) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Truist Securities Initiates Coverage of Disc Medicine (IRON) with Buy Recommendation - MSN
Lobbying Update: $50,000 of DISC MEDICINE lobbying was just disclosed - Quiver Quantitative
ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action InvestigationIRON - ACCESS Newswire
Disc Medicine Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), ... - Caledonian Record
Cantor Fitzgerald reiterates Disc Medicine stock rating on pipeline catalysts - Investing.com
Disc Medicine Insider Sold Shares Worth $2,473,780, According to a Recent SEC Filing - Moomoo
Disc Medicine CEO John Quisel sells $2.47m in shares By Investing.com - Investing.com India
Form 4 Disc Medicine Inc For: 14 July By Investing.com - Investing.com South Africa
Disc Medicine CEO John Quisel sells $2.47m in shares - Investing.com
Disc Medicine (NASDAQ: IRON) CEO exercises options and sells 33,000 shares - Stock Titan
Form 144 Disc Medicine For: 13 July By Investing.com - Investing.com South Africa
Ironwood Pharmaceuticals (NASDAQ: IRON) plans 33,000-share sale via options exercise - Stock Titan
Disc Medicine Investor News: If You Have Suffered Losses in - GlobeNewswire
Price to earnings forward of Disc Medicine, Inc. – BOATS:IRON - TradingView
Disc Medicine Inc. (IRON) Q1 2026 Earnings: Clinical Progress Amidst Market SkepticismRevenue Inflection Point - dars.gov.et
Disc Medicine COO Jonathan Yu sells $8,250 in stock By Investing.com - Investing.com Nigeria
Form 4 Disc Medicine Inc For: 9 July By Investing.com - Investing.com Canada
Disc Medicine COO Jonathan Yu sells $8,250 in stock - Investing.com
Disc Medicine (IRON) COO trades 100 shares after option exercise under 10b5-1 plan - Stock Titan
Why Disc Medicine's Extended Hercules Credit Access Could Reshape IRON's Funding Flexibility Narrative - simplywall.st
Broker files Form 144 for 10,000 IRON shares (IRON) — option exercise sale - Stock Titan
IRON Q1 2026 Earnings: Narrower-than-expected loss highlights cost control amid clinical progressLong-Term Guidance - dars.gov.et
Bronstein, Gewirtz & Grossman, LLC Is Investigating Disc Medicine, Inc. (IRON) And Encourages Investors to Connect - The National Law Review
Disc Medicine (IRON) Could Be 67% Undervalued On Its $30 Million Loan Reset - Sahm
Disc Medicine Inc Azioni (IRON) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Disc Medicine Inc Azioni (IRON) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Quisel John D | Chief Executive Officer |
Jul 13 '26 |
Sale |
74.96 |
33,000 |
2,473,780 |
226,064 |
2.44%
0.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):